TY - JOUR
AU - N. LeFevre
AU - J. St Louis
AU - E. Worringer
AU - M. Younkin
AU - N. Stahl
AU - M. Sorcinelli
A1 - 
AD - From the Department of Family and Community Medicine, University of Missouri-Columbia, Columbia, MO; Department of Family Medicine, Tufts University School of Medicine, Core Faculty, Lawrence Family Medicine Residency, Lawrence, MA (JSL); Rush-Esperanza Family Medicine Residency, Chicago, IL (EW); Harm Reduction Services, Boston Health Care for the Homeless Program, Clinical Assistant Professor, Department of Family Medicine, Tufts University School of Medicine, Boston, MA (MY); Department of Family Medicine, Tufts University School of Medicine, Addiction Consult Service, Lawrence General Hospital, Community Faculty, Lawrence Family Medicine Residency, Lawrence, MA (NS); Office Based Addiction Treatment Program, Greater Lawrence Family Health Center, Community Faculty, Lawrence Family Medicine Residency, Lawrence, MA (MS). nlefevre@health.missouri.edu.; From the Department of Family and Community Medicine, University of Missouri-Columbia, Columbia, MO; Department of Family Medicine, Tufts University School of Medicine, Core Faculty, Lawrence Family Medicine Residency, Lawrence, MA (JSL); Rush-Esperanza Family Medicine Residency, Chicago, IL (EW); Harm Reduction Services, Boston Health Care for the Homeless Program, Clinical Assistant Professor, Department of Family Medicine, Tufts University School of Medicine, Boston, MA (MY); Department of Family Medicine, Tufts University School of Medicine, Addiction Consult Service, Lawrence General Hospital, Community Faculty, Lawrence Family Medicine Residency, Lawrence, MA (NS); Office Based Addiction Treatment Program, Greater Lawrence Family Health Center, Community Faculty, Lawrence Family Medicine Residency, Lawrence, MA (MS).
AN - 37704389
BT - J Am Board Fam Med
C5 - Opioids & Substance Use; Healthcare Policy; Healthcare Disparities; Education & Workforce
CP - 5
DA - Oct 11
DO - 10.3122/jabfm.2023.230048R1
DP - NLM
ET - 20230913
IS - 5
JF - J Am Board Fam Med
LA - eng
PY - 2023
SN - 1557-2625
SP - 867
EP - 872+
ST - The End of the X-waiver: Excitement, Apprehension, and Opportunity
T1 - The End of the X-waiver: Excitement, Apprehension, and Opportunity
T2 - J Am Board Fam Med
TI - The End of the X-waiver: Excitement, Apprehension, and Opportunity
U1 - Opioids & Substance Use; Healthcare Policy; Healthcare Disparities; Education & Workforce
U3 - 10.3122/jabfm.2023.230048R1
VL - 36
VO - 1557-2625
Y1 - 2023
ER -